PRESS RELEASE published on 04/01/2024 at 22:05, 1 year 11 months ago Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity Zomedica Corp. reports consolidated financial results for Q4 and full year 2023, showing significant revenue growth and progress. CEO Larry Heaton highlights momentum and strategic acquisitions for future growth Financial Results Revenue Growth Acquisitions 2023 Zomedica Corp.
BRIEF published on 03/20/2024 at 11:35, 2 years ago Zomedica Announces Q4 and Full Year 2023 Financial Results Conference Financial Results Conference Call 2023 Performance Zomedica Veterinary Health
BRIEF published on 03/20/2024 at 11:35, 2 years ago Zomedica annonce la conférence sur les résultats financiers du quatrième trimestre et de l'exercice 2023 Résultats Financiers Zomedica Conférence Téléphonique Santé Vétérinaire Performances 2023
PRESS RELEASE published on 03/20/2024 at 11:30, 2 years ago Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET Zomedica Corp. (NYSE American: ZOM) to host conference call on April 1, 2024, discussing operational and financial highlights for Q4 and full year 2023. Company specializes in veterinary health products for companion animals Financial Results Conference Call Companion Animals Zomedica Corp. Veterinary Health
BRIEF published on 03/14/2024 at 11:35, 2 years ago Zomedica's TRUFORMA Demonstrates Superior Accuracy in Feline Hyperthyroidism Diagnosis Over CLIA Platforms Zomedica TRUFORMA Hyperthyroidism Veterinary Research Diagnostic Technology
BRIEF published on 03/14/2024 at 11:35, 2 years ago TRUFORMA de Zomedica démontre une précision supérieure dans le diagnostic de l'hyperthyroïdie féline par rapport aux plateformes CLIA Zomedica TRUFORMA Hyperthyroïdie Recherche Vétérinaire Technologie Diagnostique
PRESS RELEASE published on 03/14/2024 at 11:30, 2 years ago Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform Zomedica Corp. announced the publication of a peer-reviewed research study comparing its TRUFORMA BAW diagnostic platform to CLIA platforms for feline hyperthyroidism diagnosis, showing superior accuracy and potential for early detection Zomedica Corp. TRUFORMA BAW Diagnostic Platform Feline Hyperthyroidism Peer-reviewed Research Study
BRIEF published on 03/13/2024 at 21:50, 2 years ago Zomedica Provides NYSE American Listing Update Reverse Stock Split Compliance Zomedica Share Price NYSE American
BRIEF published on 03/13/2024 at 21:50, 2 years ago Zomedica fournit une mise à jour de la cotation américaine au NYSE Zomedica Conformité Cours De L'action NYSE Américain Regroupement D'actions
PRESS RELEASE published on 03/13/2024 at 21:45, 2 years ago Zomedica Provides NYSE American Listing Update Zomedica Corp. announces ongoing dialogue with NYSE American regarding compliance with listing standards. Shares to remain listed as Company explores options Compliance Zomedica Corp. Share Price NYSE American Listing Standards
Published on 03/24/2026 at 12:05, 19 minutes ago Faraday Copper Continues to Intersect Near-Surface Copper Mineralization at American Eagle and Expands Keel Laterally
Published on 03/24/2026 at 10:10, 2 hours 14 minutes ago BioNxt Enters Commercialization Phase with Global Patent Protection and U.S. Fast Track Strategy for Sublingual Drug Delivery Platform
Published on 03/24/2026 at 08:01, 4 hours 23 minutes ago Star Copper Confirms Copper Creek Mineralization
Published on 03/24/2026 at 07:00, 5 hours 24 minutes ago Panther Minerals Earns In Under Rubidium Ridge Project Option
Published on 03/24/2026 at 07:00, 5 hours 24 minutes ago Panther Completes Acquisition of Rubidium Ridge Project
Published on 03/24/2026 at 11:59, 25 minutes ago Vienna Soil Dialogue: AGRANA shifts focus to soil as a strategic resource key to Europe’s future
Published on 03/24/2026 at 11:45, 39 minutes ago BIOTRONIK Leaps Forward with Next‑Generation Leadless Pacing
Published on 03/24/2026 at 11:32, 52 minutes ago Correction of a release from 24.03.2026 08:00 GMT/BST - official list notice
Published on 03/24/2026 at 11:30, 54 minutes ago Infosys and University of Nottingham Extend Strategic Collaboration to Strengthen Digital Infrastructure for Student Management System
Published on 03/24/2026 at 11:20, 1 hour 4 minutes ago EQS-Adhoc: Leifheit Aktiengesellschaft: Dividend Proposal and Forecast for Financial Year 2026
Published on 03/24/2026 at 10:58, 1 hour 26 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of February 28, 2026
Published on 03/24/2026 at 10:58, 1 hour 26 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 28 février 2026
Published on 03/24/2026 at 07:45, 4 hours 39 minutes ago François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 4 hours 39 minutes ago La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 4 hours 54 minutes ago Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions